Literature DB >> 20400865

Eph-ephrin bidirectional signaling comes into the context of lymphocyte transendothelial migration.

Eva M Trinidad1, Agustín G Zapata, Luis M Alonso-Colmenar.   

Abstract

A better knowledge of the molecular mechanisms that govern leukocyte trafficking is of major relevance for the clinics. Both normal and pathologic extravasation of lymphocytes are a fine-tuned spatio-temporal event of migratory path-finding likely regulated by molecular guidance cues underlying cell movements in other systems. We have recently reported that members of the Eph family of receptor tyrosine kinases, namely EphA2 and one of its ligands, ephrin-A4 (EFNA4) can mediate in the traffic of chronic lymphocytic leukemia (CLL) cells and presumably of normal B cells between the blood and the tissues. The importance of EphA2-EFNA4 interactions at the endothelium-lymphocyte interface during TEM could rely on their attractive/repulsive properties. In the present work, we expand on those results by including additional insights and new suggestions for future studies that discuss the relevance of these molecules in overall cell adhesion dynamic events.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20400865      PMCID: PMC2958610          DOI: 10.4161/cam.4.3.11586

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  61 in total

1.  Compartmentalized signaling by GPI-anchored ephrin-A5 requires the Fyn tyrosine kinase to regulate cellular adhesion.

Authors:  A Davy; N W Gale; E W Murray; R A Klinghoffer; P Soriano; C Feuerstein; S M Robbins
Journal:  Genes Dev       Date:  1999-12-01       Impact factor: 11.361

2.  The last molecular fortress in leukocyte trans-endothelial migration.

Authors:  Michel Aurrand-Lions; Caroline Johnson-Leger; Beat A Imhof
Journal:  Nat Immunol       Date:  2002-02       Impact factor: 25.606

Review 3.  Biological and clinical heterogeneity of B-cell chronic lymphocytic leukemia.

Authors:  Giovanni D'Arena; Nicola Di Renzo; Maura Brugiatelli; Maria L Vigliotti; Michael J Keating
Journal:  Leuk Lymphoma       Date:  2003-02

4.  Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB.

Authors:  Eduard Batlle; Jeffrey T Henderson; Harry Beghtel; Maaike M W van den Born; Elena Sancho; Gerwin Huls; Jan Meeldijk; Jennifer Robertson; Marc van de Wetering; Tony Pawson; Hans Clevers
Journal:  Cell       Date:  2002-10-18       Impact factor: 41.582

Review 5.  Novel chemokine functions in lymphocyte migration through vascular endothelium under shear flow.

Authors:  G Cinamon; V Grabovsky; E Winter; S Franitza; S Feigelson; R Shamri; O Dwir; R Alon
Journal:  J Leukoc Biol       Date:  2001-06       Impact factor: 4.962

Review 6.  Impaired transendothelial migration of B-CLL lymphocytes: a defect linked to low L-selectin expression.

Authors:  B Gu; L P Dao; J Wiley
Journal:  Leuk Lymphoma       Date:  2001-06

7.  Tyrosine phosphorylation of transmembrane ligands for Eph receptors.

Authors:  K Brückner; E B Pasquale; R Klein
Journal:  Science       Date:  1997-03-14       Impact factor: 47.728

8.  Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo.

Authors:  Dana M Brantley; Nikki Cheng; Erin J Thompson; Qing Lin; Rolf A Brekken; Philip E Thorpe; Rebecca S Muraoka; Douglas Pat Cerretti; Ambra Pozzi; Dowdy Jackson; Charles Lin; Jin Chen
Journal:  Oncogene       Date:  2002-10-10       Impact factor: 9.867

Review 9.  Chronic lymphocytic leukaemia: one disease or two?

Authors:  T Hamblin
Journal:  Ann Hematol       Date:  2002-05-18       Impact factor: 3.673

10.  Subsecond induction of alpha4 integrin clustering by immobilized chemokines stimulates leukocyte tethering and rolling on endothelial vascular cell adhesion molecule 1 under flow conditions.

Authors:  V Grabovsky; S Feigelson; C Chen; D A Bleijs; A Peled; G Cinamon; F Baleux; F Arenzana-Seisdedos; T Lapidot; R R Lobb; R Alon
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

View more
  6 in total

Review 1.  EphA receptor signaling--complexity and emerging themes.

Authors:  Hui Miao; Bingcheng Wang
Journal:  Semin Cell Dev Biol       Date:  2011-10-21       Impact factor: 7.727

Review 2.  Emerging Roles for Eph Receptors and Ephrin Ligands in Immunity.

Authors:  Thayer K Darling; Tracey J Lamb
Journal:  Front Immunol       Date:  2019-07-04       Impact factor: 7.561

3.  Effective Tumor Targeting by EphA2-Agonist-Biotin-Streptavidin Conjugates.

Authors:  Parima Udompholkul; Carlo Baggio; Luca Gambini; Yu Sun; Ming Zhao; Robert M Hoffman; Maurizio Pellecchia
Journal:  Molecules       Date:  2021-06-17       Impact factor: 4.411

4.  EphrinA4 plays a critical role in α4 and αL mediated survival of human CLL cells during extravasation.

Authors:  Miguel A Flores; Paula Fortea; Eva M Trinidad; Dolores García; Gloria Soler; Francisco J Ortuño; Agustín G Zapata; Luis M Alonso-Colmenar
Journal:  Oncotarget       Date:  2016-07-26

5.  Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide-Drug Conjugate.

Authors:  Ahmed F Salem; Si Wang; Sandrine Billet; Jie-Fu Chen; Parima Udompholkul; Luca Gambini; Carlo Baggio; Hsian-Rong Tseng; Edwin M Posadas; Neil A Bhowmick; Maurizio Pellecchia
Journal:  J Med Chem       Date:  2018-02-27       Impact factor: 7.446

6.  Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic Agents.

Authors:  Ahmed F Salem; Luca Gambini; Parima Udompholkul; Carlo Baggio; Maurizio Pellecchia
Journal:  Pharmaceuticals (Basel)       Date:  2020-05-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.